How to assess and compare drugs in the management of migraine: success rates in terms of response and recurrence

被引：32

作者：

Ferrari, M ^{[1
]}

机构：

[1] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands

来源：

CEPHALALGIA | 1999年 / 19卷

关键词：

D O I：

10.1177/0333102499019S2302

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：2 / 8

页数：7

共 8 条

[1]

DAHLOF C, 1998, IN PRESS HEADACHE

[2]

*INT HEAD SOC COMM, 1991, CEPHALALGIA, V1, P1

[3] SUBCUTANEOUS SUMATRIPTAN IN A CLINICAL SETTING - THE 1ST 100 CONSECUTIVE PATIENTS WITH ACUTE MIGRAINE IN A TERTIARY CARE CENTER [J].

SHEFTELL, FD ;

WEEKS, RE ;

RAPOPORT, AM ;

SIEGEL, S ;

BASKIN, S ;

ARROWSMITH, F .

HEADACHE, 1994, 34 (02) :67-72

[4] How to define the best efficacy parameters for migraine [J].

TfeltHansen, P .

CEPHALALGIA, 1997, 17 :6-8

[5] Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response [J].

Visser, WH ;

Burggraaf, J ;

Muller, LM ;

Schoemaker, RC ;

Fowler, PA ;

Cohen, AF ;

Ferrari, MD .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (04) :452-460

[6] Sumatriptan in clinical practice: A 2-year review of 453 migraine patients [J].

Visser, WH ;

deVriend, RHM ;

Jaspers, NMWH ;

Ferrari, MD .

NEUROLOGY, 1996, 47 (01) :46-51

[7] A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine [J].

Winner, P ;

Ricalde, O ;

LeForce, B ;

Saper, J ;

Margul, B .

ARCHIVES OF NEUROLOGY, 1996, 53 (02) :180-184

[8]

YOCCA FD, 1997, CEPHALALGIA, V17, P404

← 1 →